BrainChild Bio
brainchildbio.com
Biotechnology
BrainChild Bio is a clinical-stage biotechnology company focusing on CAR-T cell therapies for central nervous system tumors, primarily in pediatric patients. The company aims to expand its technology platform to address adult indications as well.
Total Funding
$100M+
Total Rounds
1
First Raise
Sep 8, 2026
Latest Raise
Sep 8, 2026
Get notified when BrainChild Bio and companies like it raise
New funding rounds in your inbox every week 路 No noise, all Signal.
Organization Chart
Founders and leadership hierarchy for this company.
Contact details require Sales or Enterprise
Open Roles
Loading open roles...
All Funding Rounds
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 9/8/2026 | |||
Company Performance Metrics
Premium Feature
Upgrade to Premium to view Capital Momentum Score and performance metrics
BrainChild Bio 路 Never miss the next round
Who's raising next?
New funding rounds in your inbox every week 路 Free